Matches in Wikidata for { <http://www.wikidata.org/entity/Q97427846> ?p ?o ?g. }
Showing items 1 to 40 of
40
with 100 items per page.
- Q97427846 description "artículu científicu espublizáu en xunetu de 2020" @default.
- Q97427846 description "im Juli 2020 veröffentlichter wissenschaftlicher Artikel" @default.
- Q97427846 description "scientific article published on 07 July 2020" @default.
- Q97427846 description "wetenschappelijk artikel" @default.
- Q97427846 description "наукова стаття, опублікована 7 липня 2020" @default.
- Q97427846 name "First-line angiogenesis inhibitor plus erlotinib versus erlotinib alone for advanced non-small-cell lung cancer harboring an EGFR mutation" @default.
- Q97427846 name "First-line angiogenesis inhibitor plus erlotinib versus erlotinib alone for advanced non-small-cell lung cancer harboring an EGFR mutation" @default.
- Q97427846 type Item @default.
- Q97427846 label "First-line angiogenesis inhibitor plus erlotinib versus erlotinib alone for advanced non-small-cell lung cancer harboring an EGFR mutation" @default.
- Q97427846 label "First-line angiogenesis inhibitor plus erlotinib versus erlotinib alone for advanced non-small-cell lung cancer harboring an EGFR mutation" @default.
- Q97427846 prefLabel "First-line angiogenesis inhibitor plus erlotinib versus erlotinib alone for advanced non-small-cell lung cancer harboring an EGFR mutation" @default.
- Q97427846 prefLabel "First-line angiogenesis inhibitor plus erlotinib versus erlotinib alone for advanced non-small-cell lung cancer harboring an EGFR mutation" @default.
- Q97427846 P1433 Q97427846-E10C3E44-0C5B-4B51-8BCB-69924233E670 @default.
- Q97427846 P1476 Q97427846-C56120BF-224D-44C6-8F45-27F2D9F17DFE @default.
- Q97427846 P2093 Q97427846-176A3AFE-F589-424B-92CA-30772320ADE6 @default.
- Q97427846 P2093 Q97427846-BB816EDF-06BC-41F0-9C8C-48DA90C12BC4 @default.
- Q97427846 P2093 Q97427846-D48AB7C0-9467-4189-B1FA-F6F267AF6610 @default.
- Q97427846 P2093 Q97427846-DEA46899-C5E7-497E-8098-C3978457856B @default.
- Q97427846 P2093 Q97427846-FD474862-62B5-4420-BB5B-2D27472C7FDF @default.
- Q97427846 P31 Q97427846-618B421E-639B-4D81-8386-E2E04CD9BF99 @default.
- Q97427846 P356 Q97427846-4C0A1BF3-DC9C-4D71-9197-117B2C91ABA0 @default.
- Q97427846 P50 Q97427846-17360611-E70A-4726-96F1-FCC68871ADA0 @default.
- Q97427846 P577 Q97427846-8394F0C4-15D9-4CFB-A5EC-66A00344181D @default.
- Q97427846 P698 Q97427846-2170DDBF-DDB5-4AB1-90D7-CD0076A3A1AA @default.
- Q97427846 P921 Q97427846-5E6A379E-CF05-40ED-931A-A4CD48BC39AB @default.
- Q97427846 P356 S00432-020-03311-W @default.
- Q97427846 P698 32632581 @default.
- Q97427846 P1433 Q2081599 @default.
- Q97427846 P1476 "First-line angiogenesis inhibitor plus erlotinib versus erlotinib alone for advanced non-small-cell lung cancer harboring an EGFR mutation" @default.
- Q97427846 P2093 "Boris Duchemann" @default.
- Q97427846 P2093 "Christos Chouaid" @default.
- Q97427846 P2093 "Gaetan Des Guetz" @default.
- Q97427846 P2093 "Jean-Baptiste Assié" @default.
- Q97427846 P2093 "Kader Chouahnia" @default.
- Q97427846 P31 Q13442814 @default.
- Q97427846 P356 "10.1007/S00432-020-03311-W" @default.
- Q97427846 P50 Q91107924 @default.
- Q97427846 P577 "2020-07-07T00:00:00Z" @default.
- Q97427846 P698 "32632581" @default.
- Q97427846 P921 Q574834 @default.